SWTX - SpringWorks Therapeutics, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 1.48B
Enterprise value 956.95M
Trailing P/E 21.09
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.71
Enterprise value/revenue 64.18
Enterprise value/EBITDA -3.23

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 346.36%
S&P500 52-week change 31.77%
52-week high 339.78
52-week low 318.09
50-day moving average 326.07
200-day moving average 326.86

Share statistics

Avg vol (3-month) 3705.09k
Avg vol (10-day) 3749.35k
Shares outstanding 562.52M
Implied shares outstanding 6N/A
Float 839.88M
% held by insiders 16.52%
% held by institutions 1106.93%
Shares short (14 May 2023) 411.99M
Short ratio (14 May 2023) 418.81
Short % of float (14 May 2023) 423.33%
Short % of shares outstanding (14 May 2023) 419.18%
Shares short (prior month 13 Apr 2023) 411.18M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-38.07%
Return on equity (ttm)-65.41%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -295.99M
Net income avi to common (ttm)-289.04M
Diluted EPS (ttm)-4.75
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)528.14M
Total cash per share (mrq)8.47
Total debt (mrq)7.05M
Total debt/equity (mrq)1.39
Current ratio (mrq)14.24
Book value per share (mrq)8.13

Cash flow statement

Operating cash flow (ttm)-174.69M
Levered free cash flow (ttm)-103.56M